Fineotex Chemical Ltd

Fineotex Chem Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Fineotex Chemical Ltd

₹ 329 1.07%
30 Dec - close price
fineotex.com BSE: 533333 NSE: FCL
About

Incorporated in 1979, Fineotex Chemicals Ltd is engaged in the business of manufacturing auxiliaries and specialty chemicals for textiles, construction, water treatment, fertilizer, leather, and paint industries[1]

Key Points

Business Segments[1]
Textile Chemical segment: Specialty chemicals producer with a focus on textiles
chemicals. Biotex Malaysia spearheads the R&D solutions, application research and product development.
Cleaning and Hygiene segment: Products such as floor cleaners, hand-washes, sanitizers, dishwashers, and toilet bowl cleaners are manufactured. The company offers customised solutions.

Website BSE NSE
  • Market Cap ₹ 3,772 Cr.
  • Current Price ₹ 329
  • High / Low ₹ 459 / 304
  • Stock P/E 33.1
  • Book Value ₹ 51.5
  • Dividend Yield 0.49 %
  • ROCE 44.2 %
  • ROE 35.2 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company is expected to give good quarter
  • Company has delivered good profit growth of 45.1% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 27.2%
  • Company's median sales growth is 18.2% of last 10 years
  • Company's working capital requirements have reduced from 109 days to 83.0 days

Cons

  • Promoter holding has decreased over last quarter: -1.58%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Part of BSE SmallCap BSE Commodities BSE Allcap Nifty Microcap 250 Nifty Total Market

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
60 78 71 61 76 67 92 88 104 108 118 107 115
47 57 58 51 62 50 72 66 76 73 90 80 86
Operating Profit 13 21 12 10 14 18 19 22 28 35 29 26 30
OPM % 22% 27% 18% 16% 19% 26% 21% 25% 27% 32% 24% 25% 26%
2 1 1 5 2 2 2 7 8 4 14 4 11
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 1 1 1 1 1 1 1 1 1 1 2 2
Profit before tax 14 21 12 14 15 18 20 28 34 37 41 29 39
Tax % 28% 26% 12% 19% 23% 26% 25% 20% 20% 26% 19% 24% 19%
10 16 11 11 12 14 15 23 27 28 33 22 31
EPS in Rs 0.93 1.42 0.98 1.03 1.08 1.23 1.35 2.04 2.47 2.50 2.97 1.96 2.75
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
41 53 65 68 75 90 113 129 129 250 296 419 448
35 50 54 50 56 66 87 101 98 197 235 305 329
Operating Profit 5 4 11 19 19 24 25 28 31 53 61 113 119
OPM % 13% 7% 17% 27% 25% 26% 22% 22% 24% 21% 21% 27% 27%
2 5 5 4 10 8 1 -9 16 6 11 32 33
Interest 0 0 0 0 0 0 1 0 0 1 1 1 1
Depreciation 0 0 0 1 1 1 1 1 1 2 3 5 6
Profit before tax 7 8 15 22 28 30 25 17 45 57 68 141 146
Tax % 26% 28% 27% 31% 24% 29% 31% 37% 20% 23% 23% 21%
5 6 11 15 21 21 17 11 36 44 52 111 114
EPS in Rs 0.48 0.52 1.00 1.35 1.90 1.91 1.56 0.97 3.25 3.97 4.70 9.99 10.18
Dividend Payout % 10% 10% 10% 15% 5% 10% 6% 5% 9% 10% 17% 16%
Compounded Sales Growth
10 Years: 23%
5 Years: 30%
3 Years: 48%
TTM: 28%
Compounded Profit Growth
10 Years: 37%
5 Years: 45%
3 Years: 45%
TTM: 45%
Stock Price CAGR
10 Years: 32%
5 Years: 65%
3 Years: 33%
1 Year: -9%
Return on Equity
10 Years: 22%
5 Years: 24%
3 Years: 27%
Last Year: 35%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 11 11 22 22 22 22 22 22 22 22 22 22 23
Reserves 43 49 48 61 80 99 116 125 159 200 247 336 567
6 4 2 3 1 5 2 3 3 2 7 5 0
8 12 12 10 12 14 19 21 28 47 46 68 55
Total Liabilities 69 76 85 97 115 139 159 171 213 271 323 431 645
6 7 11 12 20 22 28 33 52 67 81 90 122
CWIP 0 0 0 0 0 0 0 0 3 0 0 0 0
Investments 29 25 39 48 56 64 58 62 43 28 76 149 300
33 44 36 37 39 54 73 76 115 176 165 193 223
Total Assets 69 76 85 97 115 139 159 171 213 271 323 431 645

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
1 -1 8 9 11 9 3 22 -1 13 66 69
2 5 -5 -6 -5 -8 4 -17 -6 7 -69 -11
-3 -4 -3 -2 -6 -2 -1 -2 -3 -4 -5 -23
Net Cash Flow 0 0 1 1 -1 -2 6 3 -10 17 -7 35

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 102 117 95 102 98 90 112 111 163 110 90 95
Inventory Days 52 55 40 54 71 97 86 68 121 127 80 58
Days Payable 89 102 80 91 109 92 93 94 133 109 85 91
Cash Conversion Cycle 65 69 54 64 60 94 105 85 152 128 86 61
Working Capital Days 52 86 60 86 84 124 145 128 198 145 99 83
ROCE % 11% 11% 17% 27% 30% 27% 19% 21% 27% 28% 27% 44%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
64.82% 64.82% 64.94% 64.97% 65.00% 65.04% 65.04% 65.04% 65.04% 65.03% 64.46% 62.88%
0.60% 0.25% 0.04% 1.02% 0.72% 0.71% 0.75% 0.72% 0.82% 1.45% 0.92% 3.28%
6.15% 6.15% 5.35% 4.01% 3.65% 3.65% 3.65% 3.86% 3.69% 3.70% 3.68% 3.63%
28.43% 28.78% 29.67% 29.99% 30.64% 30.62% 30.56% 30.39% 30.46% 29.83% 30.93% 30.20%
No. of Shareholders 63,04764,85172,1461,05,7101,10,8551,10,3121,13,4691,16,8011,16,0671,22,0951,26,6731,28,268

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls